Healthcare Sector
Market Tracker
15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/17/2024 | PUT | $127.00 | 5,242 | +4,963 | +1,778.85% |
| 05/17/2024 | PUT | $122.00 | 1,121 | +912 | +436.36% |
| 05/17/2024 | CALL | $129.00 | 1,112 | +702 | +171.22% |
| 05/17/2024 | PUT | $121.00 | 2,638 | +631 | +31.44% |
| 06/20/2025 | CALL | $140.00 | 1,016 | +407 | +66.83% |
| 07/19/2024 | CALL | $135.00 | 4,390 | +404 | +10.14% |
| 05/17/2024 | CALL | $135.00 | 20,478 | -15 | -0.07% |
| 05/17/2024 | CALL | $133.00 | 372 | -29 | -7.23% |
| 05/10/2024 | CALL | $127.00 | 269 | -34 | -11.22% |
| 09/20/2024 | CALL | $140.00 | 2,758 | -39 | -1.39% |
| 05/17/2024 | PUT | $125.00 | 2,173 | -96 | -4.23% |
| 05/17/2024 | PUT | $124.00 | 261 | -223 | -46.07% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.04% | 77.07M | 8.28B |
| Vanguard 500 Index Fund | 2.31% | 58.61M | 6.3B |
| Fidelity 500 Index Fund | 1.09% | 27.79M | 2.99B |
| SPDR S&P 500 ETF Trust | 1.08% | 27.45M | 2.95B |
| iShares Core S&P 500 ETF | 0.89% | 22.63M | 2.43B |
| Vanguard Index-Value Index Fund | 0.86% | 21.91M | 2.35B |
| Select Sector SPDR Fund-Health Care | 0.81% | 20.59M | 2.21B |
| Vanguard Specialized-Health Care Fund | 0.72% | 18.31M | 1.97B |
| Vanguard Institutional Index Fund-Institutional Index Fund | 0.70% | 17.77M | 1.91B |
| Schwab Strategic Tr-Schwab U.S. Dividend Equity ETF | 0.68% | 17.38M | 1.87B |
A Look at Pharma ETFs Post Q1 Earnings
05/07 11:30 am
Zacks Investment Research
Read moreShould You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RSPH)?
05/07 06:20 am
Zacks Investment Research
Read moreSCHD: A Must-Have In Every Dividend Portfolio
05/04 03:39 am
Seeking Alpha
Read moreHere's Why Merck (MRK) is a Strong Momentum Stock
05/03 09:50 am
Zacks Investment Research
Read moreJob Market Cools In April: Payrolls Miss Forecasts, Wages Rise Less Than Expected (UPDATED)
05/03 08:58 am
Benzinga
Read moreModerna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
05/02 11:14 am
Zacks Investment Research
Read moreModerna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
04/29 11:33 am
Zacks Investment Research
Read moreMerck Shines in Q1 2024 Earnings Surge
04/26 11:45 am
The Motley Fool
Read morePharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
04/26 11:34 am
Zacks Investment Research
Read moreMerck (MRK) Q1 2024 Earnings Call Transcript
04/25 03:30 pm
The Motley Fool
Read moreAstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
04/25 01:47 pm
Zacks Investment Research
Read moreStocks Drop, Tech Tumbles With Meta's Weak Outlook, Q1 Stagflation Fears; Gold Miners Advance: What's Driving Markets Thursday?
04/25 01:30 pm
Benzinga
Read moreMerck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
04/25 12:09 pm
Zacks Investment Research
Read moreMerck (MRK) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
04/25 10:30 am
Zacks Investment Research
Read moreZacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck and AbbVie
04/25 08:33 am
Zacks Investment Research
Read moreUS Stocks Brace For Negative Start Amid Tech Earnings Disappointments, Caution Ahead Of Data: 'Worst Of This Two-Week Decline Is Behind Us,' Says Analyst
04/25 06:17 am
Benzinga
Read moreWill Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
04/24 12:05 pm
Zacks Investment Research
Read more4 Large Drug Stocks to Hold on to Amid Industry Challenges
04/24 10:09 am
Zacks Investment Research
Read moreWhat's in Store for These 5 Pharma Bigwigs in Q1 Earnings?
04/24 09:19 am
Zacks Investment Research
Read moreIs Invesco Pharmaceuticals ETF (PJP) a Strong ETF Right Now?
04/24 06:20 am
Zacks Investment Research
Read moreHow Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
04/22 02:39 pm
Zacks Investment Research
Read moreExploring Analyst Estimates for Merck (MRK) Q1 Earnings, Beyond Revenue and EPS
04/22 09:15 am
Zacks Investment Research
Read moreCan Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
04/21 05:45 pm
Benzinga
Read moreWall Street Breakfast: The Week Ahead
04/21 06:46 am
Seeking Alpha
Read moreEarnings Preview: AbbVie (ABBV) Q1 Earnings Expected to Decline
04/19 10:00 am
Zacks Investment Research
Read moreUnveiling 17 Analyst Insights On Merck & Co
04/18 02:01 pm
Benzinga
Read moreMerck (MRK) Reports Next Week: Wall Street Expects Earnings Growth
04/18 10:01 am
Zacks Investment Research
Read moreMerck (MRK) Advances While Market Declines: Some Information for Investors
04/17 05:50 pm
Zacks Investment Research
Read moreTop Analyst Reports for Microsoft, Novo Nordisk & United Parcel
04/15 11:22 am
Zacks Investment Research
Read moreBetter Growth Play: Merck or The Vanguard Growth Index Fund?
04/15 09:00 am
The Motley Fool
Read moreMerck Paid $208 Million to Stop Its Drugs From Working. Here's Why That's Bullish.
04/14 05:30 am
The Motley Fool
Read more1 New Green Flag for Moderna and Merck Stock
04/12 08:45 am
The Motley Fool
Read moreMerck (MRK) Stock Slides as Market Rises: Facts to Know Before You Trade
04/11 05:50 pm
Zacks Investment Research
Read moreVaccine Player Vaxcyte Has Advantage Over Pfizer, Merck's Pneumococcal Shots - Analyst Says
04/10 02:42 pm
Benzinga
Read moreModerna (MRNA) Up 6% on Upbeat Data From Cancer Jab Study
04/10 10:59 am
Zacks Investment Research
Read moreCompany News for Apr 10, 2024
04/10 09:25 am
Zacks Investment Research
Read moreCorcept (CORT) Completes Enrollment in Ovarian Cancer Study
04/09 11:09 am
Zacks Investment Research
Read moreMerck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
04/08 11:38 pm
Zacks Investment Research
Read more2 Dividend Stocks to Buy and Hold Forever
04/08 03:46 am
The Motley Fool
Read moreDown 75%. Is Agenus Stock a Buy on the Dip?
04/08 03:34 am
The Motley Fool
Read moreMerck (MRK) Rises Yet Lags Behind Market: Some Facts Worth Knowing
04/05 05:45 pm
Zacks Investment Research
Read moreeFFECTOR Therapeutics (EFTR) Plunges 82% as NSCLC Study Fails
04/05 12:58 pm
Zacks Investment Research
Read morePharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
04/05 08:07 am
Zacks Investment Research
Read moreMerck (MRK) Begins Phase III NSCLC Study on KRAS Candidate
04/05 05:33 am
Zacks Investment Research
Read moreKintara (KTRA) Stock Soars on Merger Agreement With TuHURA
04/04 10:38 am
Zacks Investment Research
Read moreGenprex (GNPX) Expands SCLC Study of Key Candidate, Stock Up
04/04 08:57 am
Zacks Investment Research
Read moreMerck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug
04/04 05:36 am
Zacks Investment Research
Read moreMerck (MRK) Stock Sinks As Market Gains: What You Should Know
04/03 05:50 pm
Zacks Investment Research
Read moreForget Shopify: This Stock Has Made Far More Millionaires
04/03 06:30 am
The Motley Fool
Read more